{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:04:26Z","timestamp":1761861866784,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Orthopedic Clinics of North America"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.ocl.2022.06.006","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T01:15:46Z","timestamp":1663118146000},"page":"421-430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Considerations in the Sickle Cell Patient Undergoing Hip Reconstructive Surgery"],"prefix":"10.1016","volume":"53","author":[{"given":"Sara J.","family":"Sustich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin M.","family":"Stronach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey B.","family":"Stambough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Lowry","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon C.","family":"Mears","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ocl.2022.06.006_bib1","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.358","article-title":"Musculoskeletal Manifestations of Sickle Cell Disease: A Review","author":"Vaishya","year":"2015","journal-title":"Cureus"},{"key":"10.1016\/j.ocl.2022.06.006_bib2","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-pathmechdis-012418-012838","article-title":"Pathophysiology of Sickle Cell Disease","volume":"14","author":"Sundd","year":"2019","journal-title":"Annu Rev Pathol Mech Dis"},{"issue":"3","key":"10.1016\/j.ocl.2022.06.006_bib3","article-title":"Total hip arthroplasty in sickle cell hemoglobinopathies","volume":"13","author":"Jeong","year":"2005","journal-title":"Am Acad Orthopaedic Surgeons"},{"issue":"10","key":"10.1016\/j.ocl.2022.06.006_bib4","doi-asserted-by":"crossref","DOI":"10.5312\/wjo.v6.i10.776","article-title":"Surgical management of osteonecrosis of the femoral head in patients with sickle cell disease","volume":"6","author":"Kamath","year":"2015","journal-title":"World J Orthopedics"},{"issue":"4","key":"10.1016\/j.ocl.2022.06.006_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.arth.2014.10.035","article-title":"Does sickle cell disease increase risk of adverse outcomes following total hip and knee arthroplasty? A nationwide database study","volume":"30","author":"Perfetti","year":"2015","journal-title":"J\u00a0Arthroplasty"},{"issue":"2","key":"10.1016\/j.ocl.2022.06.006_bib6","doi-asserted-by":"crossref","DOI":"10.1007\/s00264-018-4001-0","article-title":"Total hip arthroplasty in osteonecrosis secondary to sickle cell disease","volume":"43","author":"Farook","year":"2019","journal-title":"Int Orthop"},{"issue":"11","key":"10.1016\/j.ocl.2022.06.006_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.arth.2016.04.025","article-title":"Quality of Life in Sickle Cell Patients After Cementless Total Hip Arthroplasty","volume":"31","author":"Azam","year":"2016","journal-title":"J\u00a0Arthroplasty"},{"issue":"2","key":"10.1016\/j.ocl.2022.06.006_bib8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ocl.2018.10.001","article-title":"Osteonecrosis of the Femoral Head","volume":"50","author":"Cohen-Rosenblum","year":"2019","journal-title":"Orthop Clin North Am"},{"issue":"3","key":"10.1016\/j.ocl.2022.06.006_bib9","article-title":"Vascularised fibular graft in the management of femoral head osteonecrosis: Twenty years later","volume":"91","author":"Korompilias","year":"2009","journal-title":"J\u00a0Bone Joint Surg - Ser B"},{"issue":"12","key":"10.1016\/j.ocl.2022.06.006_bib10","article-title":"The natural history of asymptomatic osteonecrosis of the femoral head in adults with sickle cell disease","volume":"88","author":"Hernigou","year":"2006","journal-title":"J\u00a0Bone Joint Surg - Ser A"},{"issue":"9","key":"10.1016\/j.ocl.2022.06.006_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.arth.2013.03.017","article-title":"Excellent results and minimal complications of total hip arthroplasty in sickle cell hemoglobinopathy at mid-term follow-up using cementless prosthetic components","volume":"28","author":"Issa","year":"2013","journal-title":"J\u00a0Arthroplasty"},{"issue":"2\u20133","key":"10.1016\/j.ocl.2022.06.006_bib12","article-title":"Management strategies for total hip arthroplasty in sickle cell patients","volume":"24","author":"Patel","year":"2014","journal-title":"J\u00a0Long-Term Effects Med Implants"},{"issue":"3","key":"10.1016\/j.ocl.2022.06.006_bib13","article-title":"The natural history of symptomatic osteonecrosis in adults with sickle-cell disease","volume":"85","author":"Hernigou","year":"2003","journal-title":"J\u00a0Bone Joint Surg - Ser A"},{"author":"Oyedeji","key":"10.1016\/j.ocl.2022.06.006_bib14"},{"issue":"3","key":"10.1016\/j.ocl.2022.06.006_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/(SICI)1096-8652(199911)62:3<129::AID-AJH1>3.0.CO;2-J","article-title":"The perioperative complication rate of orthopedic surgery in sickle cell disease: Report of the national sickle cell surgery study group","volume":"62","author":"Vichinsky","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ocl.2022.06.006_bib16","article-title":"Total THA in adult osteonecrosis related to sickle cell disease","volume":"466","author":"Hernigou","year":"2008","journal-title":"Clin Orthopaedics Relat Res"},{"issue":"8","key":"10.1016\/j.ocl.2022.06.006_bib17","doi-asserted-by":"crossref","DOI":"10.1007\/s12630-017-0883-3","article-title":"Perioperative considerations for patients with sickle cell disease: a narrative review","volume":"64","author":"Khurmi","year":"2017","journal-title":"Can J Anesth"},{"issue":"23","key":"10.1016\/j.ocl.2022.06.006_bib18","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM199006073222301","article-title":"Alloimmunization in Sickle Cell Anemia and Transfusion of Racially Unmatched Blood","volume":"322","author":"Vichinsky","year":"1990","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ocl.2022.06.006_bib19","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM199507273330402","article-title":"A\u00a0Comparison of Conservative and Aggressive Transfusion Regimens in the Perioperative Management of Sickle Cell Disease","volume":"333","author":"Vichinsky","year":"1995","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ocl.2022.06.006_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.tracli.2012.11.001","article-title":"Perioperative transfusion management in patients with sickle cell anaemia undergoing a total hip arthroplasty. Is there a role of red-cell exchange transfusion? A retrospective study in the CHU of Fort-de-France Martinique","volume":"20","author":"Ould Amar","year":"2013","journal-title":"Transfus Clinique Biologique"},{"issue":"2","key":"10.1016\/j.ocl.2022.06.006_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.arth.2017.09.010","article-title":"Noncemented Total Hip Arthroplasty in Sickle-Cell Disease: Long-Term Results","volume":"33","author":"Ilyas","year":"2018","journal-title":"J\u00a0Arthroplasty"},{"issue":"4","key":"10.1016\/j.ocl.2022.06.006_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/S0883-5403(97)90198-4","article-title":"Results and complications of total hip arthroplasties in patients with sickle-cell hemoglobinopathies: Role of cementless components","volume":"12","author":"Hickman","year":"1997","journal-title":"J\u00a0Arthroplasty"},{"issue":"2","key":"10.1016\/j.ocl.2022.06.006_bib23","doi-asserted-by":"crossref","DOI":"10.5144\/0256-4947.2007.112","article-title":"Revision hip arthroplasty in sickle cell disease","volume":"27","author":"Kalacy","year":"2007","journal-title":"Ann Saudi Med"},{"issue":"3","key":"10.1016\/j.ocl.2022.06.006_bib24","article-title":"Hip arthroplasty in patients with sickle-cell haemoglobinopathy","volume":"74","author":"Acurio","year":"1992","journal-title":"J\u00a0Bone Joint Surg - Ser B"},{"issue":"10","key":"10.1016\/j.ocl.2022.06.006_bib25","doi-asserted-by":"crossref","DOI":"10.1302\/2058-5241.5.190073","article-title":"Total hip arthroplasty for sickle cell osteonecrosis: guidelines for perioperative management","volume":"5","author":"Hernigou","year":"2020","journal-title":"EFORT Open Rev"},{"issue":"1","key":"10.1016\/j.ocl.2022.06.006_bib26","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2018.032","article-title":"Perioperative management of sickle cell disease","volume":"10","author":"Adjepong","year":"2018","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"9","key":"10.1016\/j.ocl.2022.06.006_bib27","doi-asserted-by":"crossref","DOI":"10.1177\/014107680209500909","article-title":"Management of pain in sickle-cell disease","volume":"95","author":"Okpala","year":"2002","journal-title":"J\u00a0R Soc Med"},{"issue":"2","key":"10.1016\/j.ocl.2022.06.006_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/(SICI)1096-8652(199606)52:2<103::AID-AJH6>3.0.CO;2-Y","article-title":"Core decompression in avascular necrosis of the hip in sickle-cell disease","volume":"52","author":"Styles","year":"1996","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.ocl.2022.06.006_bib29","doi-asserted-by":"crossref","DOI":"10.5301\/HIP.2011.8760","article-title":"Prophylactic decompression and bone grafting for small asymptomatic osteonecrotic lesions of the femoral head","volume":"21","author":"Hsu","year":"2011","journal-title":"HIP Int"},{"issue":"1","key":"10.1016\/j.ocl.2022.06.006_bib30","article-title":"Osteonecrosis of the hip in sickle cell hemoglobinopathy","volume":"24","author":"Moran","year":"1995","journal-title":"Am J Orthop"},{"issue":"1","key":"10.1016\/j.ocl.2022.06.006_bib31","doi-asserted-by":"crossref","DOI":"10.1007\/s12570-010-0006-x","article-title":"Choice of implant in total hip arthroplasty for sickle cell disease patients","volume":"1","author":"AlOmran","year":"2010","journal-title":"Eur Orthopaedics Traumatol"},{"issue":"4","key":"10.1016\/j.ocl.2022.06.006_bib32","doi-asserted-by":"crossref","DOI":"10.4103\/0019-5413.159659","article-title":"Short term results of cementless total hip arthroplasty in sicklers","volume":"49","author":"Gulati","year":"2015","journal-title":"Indian J Orthopaedics"},{"issue":"8","key":"10.1016\/j.ocl.2022.06.006_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.arth.2020.04.014","article-title":"Total Hip Arthroplasty in Patients With Sickle Cell Disease: A Comprehensive Systematic Review","volume":"35","author":"Fassihi","year":"2020","journal-title":"J\u00a0Arthroplasty"},{"issue":"3","key":"10.1016\/j.ocl.2022.06.006_bib34","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1302\/2058-5241.5.190038","article-title":"Total hip arthroplasty in sickle cell disease: A systematic review","volume":"5","author":"Kenanidis","year":"2020","journal-title":"EFORT Open Rev"},{"issue":"3","key":"10.1016\/j.ocl.2022.06.006_bib35","article-title":"Total replacement of the hip for avascular necrosis in sickle cell disease","volume":"71","author":"Clarke","year":"1989","journal-title":"J\u00a0Bone Joint Surg - Ser B"},{"issue":"349","key":"10.1016\/j.ocl.2022.06.006_bib36","first-page":"105","article-title":"Aseptic osteonecrosis of the femoral head in patients with sickle cell anemia","author":"Severyns","year":"2021","journal-title":"Morphologie"},{"key":"10.1016\/j.ocl.2022.06.006_bib37","article-title":"Impact of sickle cell disease on postoperative outcomes following total hip arthroplasty","author":"Gu","year":"2021","journal-title":"HIP Int"},{"issue":"3","key":"10.1016\/j.ocl.2022.06.006_bib38","doi-asserted-by":"crossref","DOI":"10.1034\/j.1600-0609.2000.90210.x","article-title":"Acute clinical events in 299 homozygous sickle cell patients living in france","volume":"65","author":"Neonato","year":"2000","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ocl.2022.06.006_bib39","article-title":"Antibiotic prophylaxis in total hip arthroplasty","volume":"79","author":"Espehaug","year":"1997","journal-title":"J\u00a0Bone Joint Surg - Ser B"}],"container-title":["Orthopedic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030589822000906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030589822000906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T14:49:24Z","timestamp":1758466164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0030589822000906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0030589822000906"],"URL":"https:\/\/doi.org\/10.1016\/j.ocl.2022.06.006","relation":{},"ISSN":["0030-5898"],"issn-type":[{"type":"print","value":"0030-5898"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Considerations in the Sickle Cell Patient Undergoing Hip Reconstructive Surgery","name":"articletitle","label":"Article Title"},{"value":"Orthopedic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ocl.2022.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}